News about Global Pharma

Biocon Acquires Manufacturing Facility of Eywa Pharma

The facility is acquired for a total consideration of US $7.7 million.

Global Pharma | 04/09/2023 | By Manvi |  1205

Delegation from HHS and FDA Visit Amneal Manufacturing Site in India

The visit followed the G20 Health Ministers' meeting in Gandhinagar, India, where health ministers from around the world met to discuss global health issues.

Global Pharma | 01/09/2023 | By Manvi |  1305

Zydus Receives Final Approval from USFDA for Isotretinoin Capsules USP, 10 mg, 20 mg 30 mg and 40 mg

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for Isotretinoin Capsules USP, 10 mg, 20 mg 30 mg and 40 mg (RLD: Accutane® Capsules, 10 mg, 20 mg and 40 mg: RS: Claravis 10 mg, 20 mg, 30 mg and 40 mg).

Global Pharma | 01/09/2023 | By Manvi |  868

Filament Health and Reset Pharma Enter Licensing Agreement for Botanical Psilocybin Drug Candidate

Reset Pharma will use its botanical psilocybin drug candidate, PEX010, for a phase 2 clinical trial studying demoralization syndrome.

Global Pharma | 01/09/2023 | By Manvi |  1102

Lupin Launches Propranolol Long-Acting Capsules in Canada

Propranolol LA's launch caters to the needs of Canadian patients,reaffirming Lupin's commitment.

Global Pharma | 31/08/2023 | By Manvi |  955

Strides Gets USFDA Approval for Mycophenolate Mofetil for Oral Suspension

The company has 280 cumulative ANDA filings with USFDA.

Global Pharma | 31/08/2023 | By Manvi |  1001

Unichem Laboratories Gets ANDA Approval for Prasugrel Tablets

Prasugrel tablets are indicated to reduce the rate of thrombotic CV events in patients.

Global Pharma | 31/08/2023 | By Manvi |  757

Ajanta Pharma Receives Final Approval for Topiramate Extended Release Capsules from USFDA

The company has received 50 final ANDA approvals, out of which 41 are commercialized.

Global Pharma | 31/08/2023 | By Manvi |  1259

Hvivo to Open Larger Facility in London to Meet Rising Demand

The new facility will be located in Canary Wharf.

Global Pharma | 30/08/2023 | By Manvi |  612

Orchid Pharma to Enter Consumer Business

The company manufactures formulations and APIs across segments.

Global Pharma | 30/08/2023 | By Manvi |  1321